See more : Salazar Resources Limited (SRLZF) Income Statement Analysis – Financial Results
Complete financial analysis of CARBIOTIX AB (CRBX.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CARBIOTIX AB, a leading company in the Specialty Business Services industry within the Industrials sector.
You may be interested
- Henderson Far East Income Limited (HFEL.L) Income Statement Analysis – Financial Results
- ProAssurance Corporation (PRA) Income Statement Analysis – Financial Results
- Ming Yang Smart Energy Group Limited (601615.SS) Income Statement Analysis – Financial Results
- Namyang Dairy Products Co., Ltd (003920.KS) Income Statement Analysis – Financial Results
- Roma Green Finance Limited Ordinary Shares (ROMA) Income Statement Analysis – Financial Results
CARBIOTIX AB (CRBX.ST)
About CARBIOTIX AB
Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.47M | 407.59K | 411.27K | 129.82K | 188.43K | 2.78M | 2.33M |
| Cost of Revenue | -1.99M | -1.76M | -2.18M | -3.45M | -2.98M | -1.35M | -248.47K |
| Gross Profit | 3.45M | 2.17M | 2.59M | 3.58M | 3.17M | 4.13M | 2.58M |
| Gross Profit Ratio | 235.45% | 533.01% | 629.48% | 2,755.62% | 1,681.06% | 148.42% | 110.66% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 5.52M | 4.33M | 4.53M | 3.21M | 2.21M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.76M | 0.00 | 5.52M | 4.33M | 4.53M | 3.21M | 2.21M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 16.76M | 14.42M | 13.06M | 9.56M | 8.56M | 6.13M | 3.31M |
| Cost & Expenses | 14.77M | 12.66M | 10.88M | 6.11M | 5.58M | 4.78M | 3.06M |
| Interest Income | 193.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 0.00 |
| Interest Expense | 174.62K | 971.00 | 8.30K | 5.97K | 13.52K | 24.03K | 21.98K |
| Depreciation & Amortization | 187.10K | 108.34K | 51.33K | 206.30K | 171.86K | 161.14K | 52.52K |
| EBITDA | -13.12M | -12.14M | -10.42M | -5.98M | -5.39M | -1.99M | -733.04K |
| EBITDA Ratio | -895.07% | -2,979.02% | -2,532.69% | -4,604.66% | -2,862.91% | -71.64% | -31.45% |
| Operating Income | -13.30M | -12.25M | -10.47M | -5.98M | -5.40M | -1.99M | -733.04K |
| Operating Income Ratio | -907.85% | -3,005.60% | -2,545.17% | -4,604.66% | -2,863.65% | -71.64% | -31.45% |
| Total Other Income/Expenses | -174.43K | -971.00 | -8.30K | -5.97K | -12.12K | -24.03K | -21.98K |
| Income Before Tax | -13.48M | -12.25M | -10.48M | -5.98M | -5.41M | -2.02M | -755.02K |
| Income Before Tax Ratio | -919.76% | -3,005.84% | -2,547.19% | -4,609.26% | -2,870.08% | -72.50% | -32.39% |
| Income Tax Expense | 0.00 | -111.16K | 13.91K | 802.65K | -5.71K | -161.14K | -52.52K |
| Net Income | -13.48M | -12.25M | -10.48M | -5.98M | -5.41M | -2.02M | -755.02K |
| Net Income Ratio | -919.76% | -3,005.84% | -2,547.19% | -4,609.26% | -2,870.08% | -72.50% | -32.39% |
| EPS | -0.28 | -36.16 | -35.52 | -22.56 | -26.33 | -9.80 | -3.68 |
| EPS Diluted | -0.28 | -36.16 | -35.52 | -22.56 | -26.33 | -9.80 | -3.68 |
| Weighted Avg Shares Out | 48.94M | 338.79K | 294.95K | 265.19K | 205.41K | 206.06K | 205.41K |
| Weighted Avg Shares Out (Dil) | 48.94M | 338.79K | 294.95K | 265.19K | 205.41K | 206.06K | 205.41K |
No news found for: CRBX.ST
Source: https://incomestatements.info
Category: Stock Reports